The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Growth In Market Value Is Expected For The Proliferative Diabetic Retinopathy (PDR) Market Between 2026 And 2030?
The market for proliferative diabetic retinopathy (pdr) has experienced rapid expansion in recent years. It is projected to grow from $2.69 billion in 2025 to $2.96 billion in 2026, at a compound annual growth rate (CAGR) of 10.3%. Historically, this growth can be attributed to factors such as the increasing prevalence of diabetes mellitus, wider adoption of retinal laser therapies, the expansion of ophthalmology clinics, improved access to eye care services, and the growth in diabetic screening programs.
The proliferative diabetic retinopathy (pdr) market size is anticipated to experience substantial growth in the upcoming years. It is forecast to achieve a valuation of $4.49 billion by 2030, progressing at a compound annual growth rate (CAGR) of 11.0%. This expansion during the projection period is attributed to the escalating demand for long-acting injectable therapies, the increasing adoption of AI-based retinal diagnostic solutions, the broader availability of outpatient ophthalmic procedures, a heightened focus on strategies for vision preservation, and greater investment in the management of diabetic eye diseases. Significant trends expected in the forecast period include the growing acceptance of anti-VEGF therapies, the rising application of advanced retinal imaging technologies, an increased emphasis on early screening and diagnosis, the expansion of minimally invasive surgical interventions, and enhanced integration of multidisciplinary diabetes care.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12911&type=smp
Which Drivers Are Supporting The Proliferative Diabetic Retinopathy (PDR) Market Growth?
An increase in diabetes cases is anticipated to drive the expansion of the proliferative diabetic retinopathy (PDR) market in the future. Diabetes, a chronic ailment, is defined by abnormally high blood glucose (sugar) concentrations. This condition is the primary contributor to proliferative diabetic retinopathy, a disease manageable through diverse treatments aimed at averting additional retinal harm and sustaining eyesight. For example, in June 2024, the National Health Service (NHS), a UK government body, reported an increase in diabetes cases among individuals under 40, climbing from 173,166 in 2022 to 216,440 in 2023. This notable increase signifies a troubling pattern within this demographic. Such figures demonstrate a swift rise in the incidence of diabetes among younger populations. Consequently, the growing occurrence of diabetes serves as a key impetus for the proliferative diabetic retinopathy (PDR) market.
How Are Different Segments Classified In The Proliferative Diabetic Retinopathy (PDR) Market Segment Analysis?
The proliferative diabetic retinopathy (pdr) market covered in this report is segmented –
1) By Treatment Type: Anti-VEGF (Vascular Endothelial Growth Factor) Therapy, Intraocular Steroids, Laser Surgery, Vitrectomy
2) By Mode of Administration: Injectables, Intravitreal Administration Focus, Other Mode Of Administrations
3) By Application: Hospitals, Clinics, Other Applications
Subsegments:
1) By Anti-VEGF Therapy: Aflibercept, Ranibizumab, Bevacizumab
2) By Intraocular Steroids: Triamcinolone Acetonide, Dexamethasone Implant, Fluocinolone Acetonide
3) By Laser Surgery: Focal Laser Photocoagulation, Panretinal Laser Photocoagulation
4) By Vitrectomy: Pars Plana Vitrectomy, Anterior Vitrectomy
Which Trends Are Expected To Impact The Proliferative Diabetic Retinopathy (PDR) Market?
Leading companies in the proliferative diabetic retinopathy (PDR) market are concentrating on developing innovative solutions, such as AI-based autonomous retinal screening systems and handheld fundus cameras, to enhance early detection and improve patient outcomes. These AI-based autonomous screening systems are engineered to analyze retinal images without human intervention, ensuring rapid and accurate identification of diabetic retinopathy, while handheld fundus cameras enable portable and accessible retinal imaging. For instance, in April 2024, Optomed Plc, a Finland-based medical technology company, received U.S. Food and Drug Administration (FDA) clearance for its Optomed Aurora with AEYE, a handheld AI fundus camera capable of autonomously detecting referable diabetic retinopathy, thereby extending the accessibility and efficiency of PDR screening beyond traditional clinical settings.
Who Are The Companies Driving Activity In The Proliferative Diabetic Retinopathy (PDR) Market?
Major companies operating in the proliferative diabetic retinopathy (pdr) market are Johnson And Johnson Limited, F Hoffmann La Roche Ltd, AbbVie Inc, Bayer AG, Novartis AG, Merck KGaA, Kubota Vision Inc, Teva Pharmaceutical Industries Ltd, Regeneron Pharmaceuticals Inc, Mylan NV, Santen Pharmaceutical Co Ltd, Lupin Limited, Genentech Inc, Alcon Inc, Carl Zeiss Meditec AG, Topcon Corporation, Nidek Co Ltd, Bausch And Lomb Corporation, Heidelberg Engineering GmbH, Iridex Corporation, Lumenis Ltd, Optos plc, Zeiss Meditec India Pvt Ltd, Alimera Sciences Inc
Get The Full Proliferative Diabetic Retinopathy (PDR) Market Report:
Which Region Leads The Proliferative Diabetic Retinopathy (PDR) Market In Overall Market Size?
North America was the largest region in the proliferative diabetic retinopathy market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the proliferative diabetic retinopathy (pdr) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Proliferative Diabetic Retinopathy (PDR) Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Proliferative Diabetic Retinopathy (PDR) Market 2026, By The Business Research Company
Encephalitis Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/encephalitis-treatment-global-market-report
Dysphagia Management Market Report
https://www.thebusinessresearchcompany.com/report/dysphagia-management-global-market-report
Rare Neurological Disease Treatment Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model